tüüp : |
ajaleht |
interneti link : |
http://www.cjhp-online.ca/index.php/cjhp/article/view/1579/2386 |
|
uurimisrühmad : |
Montreal - Faculté de pharmacie, Université de Montréal |
Autor : |
Friciu M, Zaraa S, Leclair G. |
pealkiri : |
Stability of Extemporaneously Compounded Amlodipine Besylate Oral Suspensions |
publikatsioon : |
Can J Hosp Pharm ; 69, 4: 327-329. 2016 |
|
Tõendite tase : |
|
füüsikaline stabiilsus : |
|
Keemiline püsivus : |
|
Muud meetodid : |
|
Kommentaarid : |
|
ingredientide nimekiri
Amlodipine besylate
|
|
|
|
|
30 mg Norvasc® |
|
23-27°C |
|
60 |
|
|
|
|
|
|
30 mg ® = Medisca Pharmaceutique Inc |
|
23-27°C |
|
60 |
|
|
|
|
|
|
30 mg Norvasc® |
|
3-7°C |
|
90 |
|
|
|
|
|
|
30 mg ® = Medisca Pharmaceutique Inc |
|
3-7°C |
|
90 |
|
|
|
|
|
|
1 mg Norvasc® |
|
23-27°C |
|
45 |
|
|
|
|
|
|
1 mg ® = Medisca Pharmaceutique Inc |
|
23-27°C |
|
45 |
|
|
|
|
|
|
1 mg Norvasc® |
|
3-7°C |
|
90 |
|
|
|
|
|
|
1 mg ® = Medisca Pharmaceutique Inc |
|
3-7°C |
|
90 |
|
|
|
|
|